Figure 2From: Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus Plasma concentration of nalbuphine in hemodialysis patients and healthy subjects following a single 30-mg dose on day 1 and a single 180-mg dose on day 13 administered orally as nalbuphine HCl ER tablets. Back to article page